TORONTO (AP) — TORONTO (AP) — COSCIENS Biopharma Inc. (CSCIF) on Tuesday reported a loss of $202,000 in its second quarter.
On a per-share basis, the Toronto-based company said it had a loss of 19 cents.
The drug developer posted revenue of $3.1 million in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CSCIF at https://www.zacks.com/ap/CSCIF
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
